Effect of Exclusive Enteral Nutrition on Disease Process, Nutritional Status and Gastrointestinal Microbiota for Chinese Children With Crohn's Disease
1 other identifier
interventional
31
1 country
1
Brief Summary
Inflammatory bowel diseases (IBD) are chronic inflammatory diseases. It is believed that the inflammation results from sustained abnormal immune response towards altered or pathogenic microbiota in genetically susceptible hosts. Malnutrition is common in IBD, especially in pediatric Crohn's disease(CD). Exclusive enteral nutrion(EEN) has been shown to improve nutritional status and inflammatory markers in pediatric CD. But there is limited data about the effect of EEN on Chinese children with CD. In this study, investigators focused on disease process,nutritional status and gut microbiome of Chinese children with newly-diagnosed CD after EEN treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2017
CompletedFirst Submitted
Initial submission to the registry
November 18, 2018
CompletedFirst Posted
Study publicly available on registry
November 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedJanuary 27, 2020
January 1, 2020
2.9 years
November 18, 2018
January 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
5-item gut microbiota measure
the change of gut microbiota during EEN and after the end of EEN
0, 2, 6, 8, 12 weeks post-EEN
2-item Simple Endoscopic Score for CD (SES-CD)
According to the SES-CD, at the end of EEN, the patients whose SES-CD scores were ≤4 were classified into the remission group (CD-RE), other patients whose SES-CD scores were \>4 were classified into the non-remission group (CD-NRE)
0, 8, weeks post-EEN
Secondary Outcomes (7)
5-item weighted Paediatric Crohn's disease activity index measure(wPCDAI)
0, 2, 6, 8, 12 weeks post-EEN
2-item 25-hydroxyvitamin D3 measure (25-OH VITD3)
0,8 weeks post-EEN
5-item weight measure
0, 2, 6, 8, 12 weeks post-EEN
5-item height measure
0, 2, 6, 8, 12 weeks post-EEN
5-item Fecal Calprotectin
0, 2, 6, 8, 12 weeks post-EEN
- +2 more secondary outcomes
Study Arms (1)
EEN group
OTHERReceived exclusive enteral nutrition after enrollment.
Interventions
a complete liquid diet of formula for 8 weeks were adminstered in Crohn's Diseas patients ,Nutritional intake was based on the child's estimated energy requirements, no regular table food during 8 weeks treament.
Eligibility Criteria
You may qualify if:
- Pediatric CD patients who were newly diagnosed and being treated with EEN at the Children's Hospital of Fudan University
You may not qualify if:
- (1) patients who were administered corticosteroids, immunosuppressive drugs, or biological agents prior to the study; (2) patients who could not finish the daily prescribed volume of formula for any reason; (3) patients who could not attend consecutive follow-up sessions; (4) patients who had received antibiotics or probiotics within 1.5 months prior to the study; and (5) patients who had been given corticosteroids, immunosuppressive drugs, biological agents, antibiotics, or probiotics during the EEN process.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's hospital of Fudan university
Shanghai, Shanghai Municipality, 201102, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- The director of gastroenterology of Children's Hospital of Fudan University
Study Record Dates
First Submitted
November 18, 2018
First Posted
November 28, 2018
Study Start
February 1, 2017
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
January 27, 2020
Record last verified: 2020-01